scholarly article | Q13442814 |
P50 | author | Ivan Maillard | Q57728609 |
Christen L Ebens | Q58123426 | ||
P2093 | author name string | Minhong Yan | |
Amy Shelton | |||
Christian W Siebel | |||
Thomas Gridley | |||
Pavan Reddy | |||
Vedran Radojcic | |||
Ashley R Sandy | |||
Linda C Samuelson | |||
Ann Friedman | |||
Ivy T Tran | |||
Jooho Chung | |||
Alexis J Carulli | |||
Gloria T Shan | |||
P2860 | cites work | Therapeutic antibody targeting of individual Notch receptors | Q27660544 |
Delta-like 1 is necessary for the generation of marginal zone B cells but not T cells in vivo | Q28509550 | ||
Dll1- and dll4-mediated notch signaling are required for homeostasis of intestinal stem cells | Q28512115 | ||
The divergent DSL ligand Dll3 does not activate Notch signaling but cell autonomously attenuates signaling induced by other DSL ligands | Q28584296 | ||
Notch activation induces apoptosis in neural progenitor cells through a p53-dependent pathway | Q28592687 | ||
Direct regulation of Gata3 expression determines the T helper differentiation potential of Notch | Q28594879 | ||
The canonical Notch signaling pathway: unfolding the activation mechanism | Q29547725 | ||
Notch/gamma-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells | Q29614268 | ||
Notch1 loss of heterozygosity causes vascular tumors and lethal hemorrhage in mice. | Q30497988 | ||
The cytolytic molecules Fas ligand and TRAIL are required for murine thymic graft-versus-host disease | Q33559627 | ||
Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter | Q33936032 | ||
Hedgehog signaling is dispensable for adult hematopoietic stem cell function | Q34039421 | ||
Notch2 is preferentially expressed in mature B cells and indispensable for marginal zone B lineage development | Q34197865 | ||
Function of NKG2D in natural killer cell-mediated rejection of mouse bone marrow grafts | Q34313946 | ||
The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation | Q34446665 | ||
Adoptive transfer of T-cell precursors enhances T-cell reconstitution after allogeneic hematopoietic stem cell transplantation | Q34561047 | ||
Notch signaling is a critical regulator of allogeneic CD4+ T-cell responses mediating graft-versus-host disease. | Q34568892 | ||
Notch2 governs the rate of generation of mouse long- and short-term repopulating stem cells | Q34627216 | ||
Growth suppression of pre-T acute lymphoblastic leukemia cells by inhibition of notch signaling | Q34811698 | ||
Graft-versus-leukemia effects of transplantation and donor lymphocytes | Q34887477 | ||
A novel tumour-suppressor function for the Notch pathway in myeloid leukaemia. | Q34978382 | ||
Blockade of Notch ligand δ1 promotes allograft survival by inhibiting alloreactive Th1 cells and cytotoxic T cell generation | Q35401923 | ||
Notch signaling modulates proliferation and differentiation of intestinal crypt base columnar stem cells. | Q35655623 | ||
Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes. | Q35847425 | ||
T cell-depleted partial matched unrelated donor transplant for advanced myeloid malignancy: KIR ligand mismatch and outcome. | Q35871747 | ||
Regulation of lymphoid development, differentiation, and function by the Notch pathway. | Q36072476 | ||
Hierarchy of Notch-Delta interactions promoting T cell lineage commitment and maturation | Q36229695 | ||
Peculiar immunobiology of bone marrow allografts. II. Rejection of parental grafts by resistant F 1 hybrid mice | Q36271368 | ||
Prophylaxis and treatment of acute graft-versus-host disease | Q36368115 | ||
Notch signaling is an important regulator of type 2 immunity. | Q36403646 | ||
Induction of tumor immunity following allogeneic stem cell transplantation | Q36490755 | ||
Loss of intestinal crypt progenitor cells owing to inactivation of both Notch1 and Notch2 is accompanied by derepression of CDK inhibitors p27Kip1 and p57Kip2. | Q36528951 | ||
Dendritic cell-mediated NK cell activation is controlled by Jagged2-Notch interaction. | Q36657491 | ||
Immunobiology of allogeneic hematopoietic stem cell transplantation | Q36665305 | ||
Notch signalling during peripheral T-cell activation and differentiation | Q36684906 | ||
Graft-versus-host disease | Q36793622 | ||
Delta-like 4 is the essential, nonredundant ligand for Notch1 during thymic T cell lineage commitment. | Q36946535 | ||
Canonical notch signaling is dispensable for the maintenance of adult hematopoietic stem cells | Q37029646 | ||
Clinical strategies to enhance posttransplant immune reconstitution | Q37045948 | ||
Acute graft-versus-host disease-challenge for a broader application of allogeneic hematopoietic cell transplantation | Q37066454 | ||
HLA-C-dependent prevention of leukemia relapse by donor activating KIR2DS1. | Q37157198 | ||
Gamma-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemia | Q37215995 | ||
Targeting the Notch1 and mTOR pathways in a mouse T-ALL model | Q37234630 | ||
gamma-Secretase in biology and medicine | Q37375252 | ||
The different faces of Notch in T-helper-cell differentiation | Q37376021 | ||
Notch and disease: a growing field | Q37988987 | ||
Killer-cell immunoglobulin-like receptors reactivity and outcome of stem cell transplant | Q38007344 | ||
Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis | Q40191484 | ||
Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis | Q40191493 | ||
Notch ligation by Delta1 inhibits peripheral immune responses to transplantation antigens by a CD8+ cell-dependent mechanism. | Q40271483 | ||
Induction of T cell development from hematopoietic progenitor cells by delta-like-1 in vitro. | Q40683787 | ||
Evidence for a similar or common mechanism for natural killer cell activity and resistance to hemopoietic grafts | Q40828092 | ||
T killer cells play a role in allogeneic bone marrow graft rejection but not in hybrid resistance | Q41487669 | ||
Parietal cell hyperstimulation and autoimmune gastritis in cholera toxin transgenic mice | Q42488991 | ||
An immunomodulatory function for neutrophils during the induction of a CD4+ Th2 response in BALB/c mice infected with Leishmania major | Q43424199 | ||
Durable engraftment of major histocompatibility complex-incompatible cells after nonmyeloablative conditioning with fludarabine, low-dose total body irradiation, and posttransplantation cyclophosphamide | Q43806522 | ||
Deficient T cell fate specification in mice with an induced inactivation of Notch1. | Q45345200 | ||
Mastermind critically regulates Notch-mediated lymphoid cell fate decisions. | Q45345202 | ||
Requirement for Notch1 signals at sequential early stages of intrathymic T cell development | Q45345203 | ||
Notch signaling controls the generation and differentiation of early T lineage progenitors | Q45345206 | ||
Overexpression of the Notch ligand, Jagged-1, induces alloantigen-specific human regulatory T cells | Q45863413 | ||
Notch1 expression on T cells is not required for CD4+ T helper differentiation | Q47431184 | ||
Instruction of distinct CD4 T helper cell fates by different notch ligands on antigen-presenting cells | Q47619638 | ||
Regulation of T lymphopoiesis by Notch1 and Lunatic fringe-mediated competition for intrathymic niches. | Q50937939 | ||
Generation of new Notch2 mutant alleles. | Q54623726 | ||
Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation. | Q55033128 | ||
Induction of Immunity and of Unresponsiveness to Parental Marrow Grafts in Adult F1 Hybrid Mice | Q58956448 | ||
Chronic DLL4 blockade induces vascular neoplasms | Q59082154 | ||
Natural killer (NK)-cell function and antileukemic activity of a large population of CD3+/CD8+ T cells expressing NK receptors for major histocompatibility complex class I after "three-loci" HLA-incompatible bone marrow transplantation | Q71029776 | ||
An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin | Q71881409 | ||
Serrate1-induced notch signalling regulates the decision between immunity and tolerance made by peripheral CD4(+) T cells | Q73399528 | ||
Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype | Q77437408 | ||
Notch signaling in the immune system | Q82881379 | ||
Graft-versus-host disease | Q83468020 | ||
Effect of Ly49 Haplotype Variance on NK Cell Function and Education | Q85057145 | ||
P4510 | describes a project that uses | ImageJ | Q1659584 |
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1590-1604 | |
P577 | publication date | 2013-04-01 | |
P1433 | published in | Journal of Clinical Investigation | Q3186904 |
P1476 | title | Blockade of individual Notch ligands and receptors controls graft-versus-host disease | |
P478 | volume | 123 |
Q37052477 | ADAM Proteases and Gastrointestinal Function |
Q27687130 | Acute graft-versus-host disease: a bench-to-bedside update |
Q54937398 | Advance in Targeted Immunotherapy for Graft-Versus-Host Disease. |
Q46214552 | BCL6 Antagonizes NOTCH2 to Maintain Survival of Human Follicular Lymphoma Cells |
Q38661579 | Cellular and molecular mechanisms in graft-versus-host disease |
Q38782516 | Combinatorial microenvironmental regulation of liver progenitor differentiation by Notch ligands, TGFβ, and extracellular matrix |
Q36199919 | Control of peripheral tolerance by regulatory T cell-intrinsic Notch signaling. |
Q40361007 | Cutting Edge: Notch Signaling Promotes the Plasticity of Group-2 Innate Lymphoid Cells. |
Q38957582 | DLL4+ dendritic cells: Key regulators of Notch Signaling in effector T cell responses |
Q61803781 | Dendritic Cell Regulation of Graft-Vs.-Host Disease: Immunostimulation and Tolerance |
Q37730667 | Fibroblastic niches prime T cell alloimmunity through Delta-like Notch ligands |
Q89722136 | GCNT1-Mediated O-Glycosylation of the Sialomucin CD43 Is a Sensitive Indicator of Notch Signaling in Activated T Cells |
Q57022244 | Helminth-Induced Production of TGF-β and Suppression of Graft-versus-Host Disease Is Dependent on IL-4 Production by Host Cells |
Q37397830 | IRF4 controls the positioning of mature B cells in the lymphoid microenvironments by regulating NOTCH2 expression and activity. |
Q48517212 | Immunotherapies in transplantation and cancer: 22nd NAT meeting/2nd NAT LabEx IGO joint meeting; 1-2 June 2017, Nantes, France |
Q46670439 | Inhibition of Delta-induced Notch signaling using fucose analogs. |
Q40018531 | Inhibition of Notch1 promotes hedgehog signalling in a HES1-dependent manner in chondrocytes and exacerbates experimental osteoarthritis. |
Q34980164 | Intestinal helminths regulate lethal acute graft-versus-host disease and preserve the graft-versus-tumor effect in mice. |
Q58723519 | Jagged1/Notch2 controls kidney fibrosis via Tfam-mediated metabolic reprogramming |
Q91993914 | Multi-Faceted Notch in Allergic Airway Inflammation |
Q58789958 | NOTCH and Graft-Versus-Host Disease |
Q37681701 | Notch Ligand DLL4 Alleviates Allergic Airway Inflammation via Induction of a Homeostatic Regulatory Pathway |
Q40375954 | Notch Ligand Delta-like 4 Promotes Regulatory T Cell Identity in Pulmonary Viral Infection |
Q47418597 | Notch Signaling Regulates the Homeostasis of Tissue-Restricted Innate-like T Cells. |
Q38949407 | Notch Signaling and Alloreactivity. |
Q55422791 | Notch Signaling and Immune Regulation in Alloimmunity. |
Q46795621 | Notch Signaling in Development, Tissue Homeostasis, and Disease |
Q39274325 | Notch Signaling in T Helper Cell Subsets: Instructor or Unbiased Amplifier? |
Q34157487 | Notch activation as a driver of osteogenic sarcoma |
Q58544241 | Notch and Wnt Dysregulation and Its Relevance for Breast Cancer and Tumor Initiation |
Q33600442 | Notch as a Driver of Gastric Epithelial Cell Proliferation |
Q35612269 | Notch receptor regulation of intestinal stem cell homeostasis and crypt regeneration |
Q39100271 | Notch regulates Th17 differentiation and controls trafficking of IL-17 and metabolic regulators within Th17 cells in a context-dependent manner |
Q38723830 | Notch regulation of gastrointestinal stem cells |
Q34218967 | Notch signaling at later stages of NK cell development enhances KIR expression and functional maturation |
Q37325713 | Notch signaling in hematopoietic cell transplantation and T cell alloimmunity. |
Q37625991 | Notch signaling in skeletal stem cells |
Q37075692 | Notch signaling regulates T cell accumulation and function in the central nervous system during experimental autoimmune encephalomyelitis. |
Q35041145 | Notch signaling regulates antigen sensitivity of naive CD4+ T cells by tuning co-stimulation |
Q26765033 | Notch signaling: its roles and therapeutic potential in hematological malignancies |
Q37227163 | Notch1 and Notch2 receptors regulate mouse and human gastric antral epithelial cell homoeostasis |
Q58086739 | Nrf2 regulates CD4 T cell-induced acute graft-versus-host disease in mice |
Q90149561 | Pharmacological inhibition of Notch signaling regresses pre-established abdominal aortic aneurysm |
Q35007792 | Phase 2 study of RO4929097, a gamma-secretase inhibitor, in metastatic melanoma: SWOG 0933. |
Q37035843 | Programming of donor T cells using allogeneic δ-like ligand 4-positive dendritic cells to reduce GVHD in mice. |
Q49716068 | Progress on signal transduction in graft-versus-host disease |
Q38105858 | Regulation of innate and adaptive immunity by Notch |
Q34017104 | Rescue of notch-1 signaling in antigen-specific CD8+ T cells overcomes tumor-induced T-cell suppression and enhances immunotherapy in cancer |
Q39455125 | Role of ADAM10 in intestinal crypt homeostasis and tumorigenesis |
Q91028577 | Sox7 is involved in antibody-dependent endothelial cell activation and renal allograft injury via the Jagged1-Notch1 pathway |
Q34463833 | Structural biology. Structural basis for Notch1 engagement of Delta-like 4 |
Q40172231 | T Cell-Restricted Notch Signaling Contributes to Pulmonary Th1 and Th2 Immunity during Cryptococcus neoformans Infection. |
Q51093744 | T cells take directions from supporting cast in graft-versus-host disease. |
Q38796193 | Targeting the Notch Pathway to Prevent Rejection. |
Q35554465 | The NOTCH signaling pathway in normal and malignant blood cell production |
Q52872585 | The NOTCH1/CD39 axis: a Treg trip-switch for GvHD. |
Q42439250 | The Notch Ligand DLL4 Defines a Capability of Human Dendritic Cells in Regulating Th1 and Th17 Differentiation. |
Q47432109 | The Notch pathway inhibitor stapled α-helical peptide derived from mastermind-like 1 (SAHM1) abrogates the hallmarks of allergic asthma. |
Q40411894 | The Varied Roles of Notch in Cancer |
Q37390250 | The histone methyltransferase Ezh2 is a crucial epigenetic regulator of allogeneic T-cell responses mediating graft-versus-host disease |
Q38208211 | Therapeutic modulation of Notch signalling--are we there yet? |
Q41105711 | Tissue-Specific Expression Patterns of MicroRNA during Acute Graft-versus-Host Disease in the Rat. |
Q36925951 | Transcriptome analysis of GVHD reveals aurora kinase A as a targetable pathway for disease prevention |
Q35164666 | Transient blockade of delta-like Notch ligands prevents allograft rejection mediated by cellular and humoral mechanisms in a mouse model of heart transplantation. |
Q38742863 | Tregs: hype or hope for allogeneic hematopoietic stem cell transplantation? |
Search more.